Journal of Medicinal Chemistry p. 2372 - 2390 (2020)
Update date:2022-08-15
Topics:
González-Gil, Inés
Zian, Debora
Vázquez-Villa, Henar
Hernández-Torres, Gloria
Martínez, R. Fernando
Khiar-Fernández, Nora
Rivera, Richard
Kihara, Yasuyuki
Devesa, Isabel
Mathivanan, Sakthikumar
Del Valle, Cristina Rosell
Zambrana-Infantes, Emma
Puigdomenech, María
Cincilla, Giovanni
Sanchez-Martinez, Melchor
Rodríguez De Fonseca, Fernando
Ferrer-Montiel, Antonio V.
Chun, Jerold
López-Vales, Rubén
López-Rodríguez, María L.
Ortega-Gutiérrez, Silvia
Neuropathic pain (NP) is a complex chronic pain state with a prevalence of almost 10% in the general population. Pharmacological options for NP are limited and weakly effective, so there is a need to develop more efficacious NP attenuating drugs. Activation of the type 1 lysophosphatidic acid (LPA1) receptor is a crucial factor in the initiation of NP. Hence, it is conceivable that a functional antagonism strategy could lead to NP mitigation. Here we describe a new series of LPA1 agonists among which derivative (S)-17 (UCM-05194) stands out as the most potent and selective LPA1 receptor agonist described so far (Emax = 118%, EC50 = 0.24 μM, KD = 19.6 nM; inactive at autotaxin and LPA2-6 receptors). This compound induces characteristic LPA1-mediated cellular effects and prompts the internalization of the receptor leading to its functional inactivation in primary sensory neurons and to an efficacious attenuation of the pain perception in an in vivo model of NP.
View MoreAngelisun(Chongqing) Pharmaceutical Co., LTD.
Contact:+86-23-68030926-816
Address:D1-7 Tech & Entrepreneurs Park, Kecheng Road, Erlang Hi-Tech Areas, Chongqing, China
Contact:86-371-63655023
Address:No.85,jinshui road,zhengzhou,China
Contact:+44 (0)161 367 9441
Address:
qingdao goldenchem imp and exp co.,ltd.
Contact:532-55579246
Address:no.62 ,haier road laoshan distirct
Jinan Yijialian Economic and Trade Development Co., Ltd.
Contact:+86 0531-66729596
Address:jinan
Doi:10.1016/j.mencom.2015.03.013
(2015)Doi:10.1021/jo01056a004
(1962)Doi:10.1080/10426500500327071
(2006)Doi:10.1016/S0040-4039(00)99369-9
(1989)Doi:10.1016/0040-4020(72)88081-5
(1972)Doi:10.1021/om010645n
(2002)